These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35329966)

  • 1. Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission.
    Larsen K; Spencer H; Mohan M; Bailey C; Hill K; Kottarathara M; Parikh R; Hoque S; Erra A; Mitma AA; Mathur P; Yarlagadda L; Gundarlapalli S; Ogunsesan Y; Hussain M; Thalambedu N; Sehti J; Al Hadidi S; Thanendrarajan S; Graziutti M; Zangari M; Barlogie B; van Rhee F; Tricot G; Schinke C
    J Clin Med; 2022 Mar; 11(6):. PubMed ID: 35329966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Performance Status and Hematopoietic Cell Transplantation Specific Comorbidity Index on Unplanned Admission Rates in Patients with Multiple Myeloma Undergoing Outpatient Autologous Stem Cell Transplantation.
    Obiozor C; Subramaniam DP; Divine C; Shune L; Singh AK; Lin TL; Abhyankar S; Chen GJ; McGuirk J; Ganguly S
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1641-1645. PubMed ID: 28603071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outpatient autologous stem cell transplantation in Royal Hobart Hospital, Tasmania: a single-centre, retrospective review in the Australian setting.
    Tan XN; Yew CY; Ragg SJ; Harrup RA; Johnston AM
    Intern Med J; 2022 Jul; 52(7):1242-1250. PubMed ID: 33949777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of febrile neutropenia among patients with multiple myeloma or lymphoma who undergo inpatient versus outpatient autologous stem cell transplantation: a systematic review and meta-analysis.
    Owattanapanich W; Suphadirekkul K; Kunacheewa C; Ungprasert P; Prayongratana K
    BMC Cancer; 2018 Nov; 18(1):1126. PubMed ID: 30445930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in delivery of ambulatory autologous stem cell transplantation for multiple myeloma.
    Khouri J; Majhail NS
    Curr Opin Support Palliat Care; 2017 Dec; 11(4):361-365. PubMed ID: 28922292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comparative Assessment of Quality of Life in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation Through an Outpatient and Inpatient Model.
    Martino M; Ciavarella S; De Summa S; Russo L; Meliambro N; Imbalzano L; Gallo GA; Moscato T; Messina G; Ferreri A; Cuzzola M; Irrera G; Naso V; Cimminiello M; Console G; Loseto G; Tommasi S; Guarini A
    Biol Blood Marrow Transplant; 2018 Mar; 24(3):608-613. PubMed ID: 29032271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and cost-effectiveness of outpatient autologous stem cell transplantation in patients with multiple myeloma.
    Holbro A; Ahmad I; Cohen S; Roy J; Lachance S; Chagnon M; LeBlanc R; Bernard L; Busque L; Roy DC; Sauvageau G; Kiss TL
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):547-51. PubMed ID: 23253556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Burden in Caregivers of Multiple Myeloma Patients Undergoing Outpatient Autologous Stem-Cell Transplantation Compared to Inpatient Transplantation.
    Martino M; Pitino A; Tripepi G; Paviglianiti A; Russo L; Cusumano G; Rossetti A; Provenzano PF; Porto G; Meliambro N; Gallo S; Porcino D; Romeo V; Gangemi T; D'Arrigo G; Imbalzano L; Console G; Gori M
    Clin Lymphoma Myeloma Leuk; 2021 Apr; 21(4):e402-e409. PubMed ID: 33288484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose chemotherapy plus autologous stem-cell transplantation as consolidation therapy in patients with relapsed multiple myeloma after previous autologous stem-cell transplantation (NCRI Myeloma X Relapse [Intensive trial]): a randomised, open-label, phase 3 trial.
    Cook G; Williams C; Brown JM; Cairns DA; Cavenagh J; Snowden JA; Ashcroft AJ; Fletcher M; Parrish C; Yong K; Cavet J; Hunter H; Bird JM; Chalmers A; O'Connor S; Drayson MT; Morris TC;
    Lancet Oncol; 2014 Jul; 15(8):874-85. PubMed ID: 24948586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma.
    Martino M; Lemoli RM; Girmenia C; Castagna L; Bruno B; Cavallo F; Offidani M; Scortechini I; Montanari M; Milone G; Postacchini L; Olivieri A
    Bone Marrow Transplant; 2016 Aug; 51(8):1032-40. PubMed ID: 27042841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous stem cell transplantation for multiple myeloma patients aged ≥ 75 treated with novel agents.
    Vaxman I; Visram A; Kumar S; Dispenzieri A; Buadi F; Dingli D; Lacy M; Muchtar E; Kapoor P; Hogan W; Hayman S; Leung N; Gonsalves W; Kourelis T; Warsame R; Berger T; Gertz MA
    Bone Marrow Transplant; 2021 May; 56(5):1144-1150. PubMed ID: 33273658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outpatient Autologous Stem Cell Transplants for Multiple Myeloma: Analysis of Safety and Outcomes in a Tertiary Care Center.
    Kodad SG; Sutherland H; Limvorapitak W; Abou Mourad Y; Barnett MJ; Forrest D; Gerrie A; Hogge DE; Nantel SH; Narayanan S; Nevill T; Power M; Sanford D; Toze C; White J; Broady R; Song K
    Clin Lymphoma Myeloma Leuk; 2019 Dec; 19(12):784-790. PubMed ID: 31678079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inpatient mortality of patients with multiple myeloma and renal impairment undergoing autologous stem cell transplantation.
    Mohyuddin GR; Abbasi S; Okoniewski M; McClune B; Abdallah AO; Ganguly S; McGuirk J; Shune L
    Eur J Haematol; 2020 Nov; 105(5):571-577. PubMed ID: 32662224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem Cell Harvesting after Bortezomib-Based Reinduction for Myeloma Relapsing after Autologous Transplantation: Results from the British Society of Blood and Marrow Transplantation/United Kingdom Myeloma Forum Myeloma X (Intensive) Trial.
    Parrish C; Morris CTCM; Williams CD; Cairns DA; Cavenagh J; Snowden JA; Ashcroft J; Cavet J; Hunter H; Bird JM; Chalmers A; Brown JM; Yong K; Schey S; Chown S; Cook G;
    Biol Blood Marrow Transplant; 2016 Jun; 22(6):1009-1016. PubMed ID: 26827659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits of Autologous Stem Cell Transplantation for Elderly Myeloma Patients in the Last Quarter of Life.
    Joseph NS; Gupta VA; Wyman S; Graiser M; Kaufman JL; Almaula D; Andrews J; Hofmeister C; Dhodapkar M; Heffner LT; Lonial S; Nooka AK
    Transplant Cell Ther; 2022 Feb; 28(2):75.e1-75.e7. PubMed ID: 34626863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation.
    Kim JS; Kim K; Cheong JW; Min YH; Suh C; Kim H; Jo DY; Ryoo HM; Yoon SS; Lee JH;
    Biol Blood Marrow Transplant; 2009 Apr; 15(4):463-70. PubMed ID: 19285634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factors for Catheter-Related Thrombosis in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation.
    Hoppe A; Rupa-Matysek J; Małecki B; Dytfeld D; Hoppe K; Gil L
    Medicina (Kaunas); 2021 Sep; 57(10):. PubMed ID: 34684057
    [No Abstract]   [Full Text] [Related]  

  • 18. Outpatient-based peripheral blood stem cell transplantation for patients with multiple myeloma.
    Ferrara F; Palmieri S; Viola A; Copia C; Schiavone EM; De Simone M; Pocali B; D'Amico MR; Annunziata M; Mele G
    Hematol J; 2004; 5(3):222-6. PubMed ID: 15167908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous stem cell transplantation for elderly patients with newly diagnosed multiple myeloma in the era of novel agents.
    Merz M; Neben K; Raab MS; Sauer S; Egerer G; Hundemer M; Hose D; Kunz C; Heiß C; Ho AD; Goldschmidt H; Hillengass J
    Ann Oncol; 2014 Jan; 25(1):189-95. PubMed ID: 24356629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A Propensity Score Matching Study of Autologous Hematopoietic Stem Cell Transplantation and New Drug Chemotherapy for Newly Diagnosed Multiple Myeloma].
    Yang FY; Wang HF; Xia LH; Wang QQ; Qian CJ; He J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):158-165. PubMed ID: 35123620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.